Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Jaeger

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Annals of Hematology|December 22, 2011
Plasmacytic differentiation in MALT lymphomas following treatment with rituximabMarlene Troch, Barbara Kiesewetter, Werner Dolak, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 1, 2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at stagingChiara Giraudo, Georgios Karanikas, Michael Weber, et al.
Frontiers in Medicine|June 20, 2024
A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines AgencyIvana Silva, Giulia Gabrielli, Juan Garcia Burgos, et al.
Psychodynamic Psychiatry|May 21, 2019
Changes in Personality Functioning After Inpatient Psychodynamic Therapy: A Dimensional Approach to Personality DisordersFalk Leichsenring, Ulrich Jaeger, Oliver Masuhr, et al.
Psychotherapy and Psychosomatics|July 31, 2020
To Be or Not to Be Improved: Patients' Perception of Symptom Improvement - Linking the SCL-90-R to Patient-Rated Global Improvement in a Large Real-World Treatment SampleFalk Leichsenring, Ulrich Jaeger, Oliver Masuhr, et al.
European Journal of Internal Medicine|November 7, 2009
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AMLAlexandra Boehm, Matthias Mayerhofer, Susanne Herndlhofer, et al.
American Journal of Clinical Pathology|March 13, 2002
The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discriminationRenate Thalhammer-Scherrer, Gerlinde Mitterbauer, Ingrid Simonitsch, et al.
Clinical Lymphoma|March 30, 2005
Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disordersStephen A Johnson, Roger G Owen, David G Oscier, et al.
The American Journal of Psychiatry|July 3, 2009
Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trialFalk Leichsenring, Simone Salzer, Ulrich Jaeger, et al.
Journal of Psychopathology and Clinical Science|February 22, 2023
Pathological personality in relation to multiple domains of quality of life and impairment: Evidence for the specific relevance of the maladaptive poles of major trait domainsKelsey A Hobbs, Frank D Mann, Robert D Latzman, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Annals of Hematology|December 22, 2011
Plasmacytic differentiation in MALT lymphomas following treatment with rituximabMarlene Troch, Barbara Kiesewetter, Werner Dolak, et al.
Journal of Magnetic Resonance Imaging : JMRI|November 1, 2017
Correlation between glycolytic activity on [18F]-FDG-PET and cell density on diffusion-weighted MRI in lymphoma at stagingChiara Giraudo, Georgios Karanikas, Michael Weber, et al.
Frontiers in Medicine|June 20, 2024
A decade of collaboration in medicines regulation: healthcare professionals engaging with the European Medicines AgencyIvana Silva, Giulia Gabrielli, Juan Garcia Burgos, et al.
Psychodynamic Psychiatry|May 21, 2019
Changes in Personality Functioning After Inpatient Psychodynamic Therapy: A Dimensional Approach to Personality DisordersFalk Leichsenring, Ulrich Jaeger, Oliver Masuhr, et al.
Psychotherapy and Psychosomatics|July 31, 2020
To Be or Not to Be Improved: Patients' Perception of Symptom Improvement - Linking the SCL-90-R to Patient-Rated Global Improvement in a Large Real-World Treatment SampleFalk Leichsenring, Ulrich Jaeger, Oliver Masuhr, et al.
European Journal of Internal Medicine|November 7, 2009
Evaluation of in vivo antineoplastic effects of rapamycin in patients with chemotherapy-refractory AMLAlexandra Boehm, Matthias Mayerhofer, Susanne Herndlhofer, et al.
American Journal of Clinical Pathology|March 13, 2002
The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discriminationRenate Thalhammer-Scherrer, Gerlinde Mitterbauer, Ingrid Simonitsch, et al.
Clinical Lymphoma|March 30, 2005
Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disordersStephen A Johnson, Roger G Owen, David G Oscier, et al.
The American Journal of Psychiatry|July 3, 2009
Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trialFalk Leichsenring, Simone Salzer, Ulrich Jaeger, et al.
Journal of Psychopathology and Clinical Science|February 22, 2023
Pathological personality in relation to multiple domains of quality of life and impairment: Evidence for the specific relevance of the maladaptive poles of major trait domainsKelsey A Hobbs, Frank D Mann, Robert D Latzman, et al.
Pageof 11